Core Viewpoint - The company, Shandong Bailong Chuangyuan Biotechnology Co., Ltd., is experiencing growth driven by its health sweetener products, particularly allulose, and benefits from its stake in a rural commercial bank, as well as the depreciation of the RMB [2][3][4]. Group 1: Company Overview - The company specializes in the research, production, and sales of prebiotic products, dietary fiber products, other starch sugar (alcohol) products, and health sweeteners [8]. - The revenue composition of the company includes dietary fiber series (54.15%), prebiotic series (28.00%), health sweeteners (13.57%), and others (3.91%) [8]. Group 2: Financial Performance - For the period from January to September 2025, the company achieved a revenue of 969 million yuan, representing a year-on-year growth of 18.10%, and a net profit attributable to the parent company of 265 million yuan, with a year-on-year increase of 44.93% [9]. - The company has distributed a total of 204 million yuan in dividends since its A-share listing, with 193 million yuan in the last three years [10]. Group 3: Market Position and Recognition - The company is recognized as a "specialized, refined, distinctive, and innovative" enterprise, which is a prestigious title for small and medium-sized enterprises in China, indicating its strong market position and innovation capabilities [4]. - The company has established good cooperative relationships with numerous well-known domestic and international enterprises, accumulating a large number of quality customer resources [4]. Group 4: Stock Performance and Investor Activity - The stock price of Bailong Chuangyuan increased by 1.16% on January 5, with a trading volume of 144 million yuan and a turnover rate of 1.56%, leading to a total market capitalization of 9.177 billion yuan [1]. - As of December 19, the number of shareholders in Bailong Chuangyuan was 11,600, a decrease of 5.87% from the previous period, with an average of 36,348 circulating shares per person, an increase of 6.23% [9].

1月5日，莱茵生物（维权）盘中上涨2.01%，截至13:06，报8.62元/股，成交7962.63万元，换手率 1.27%，总市值63.93亿元。 资金流向方面，主力资金净流入116.79万元，特大单买入0.00元，占比0.00%，卖出127.77万元，占比 1.60%；大单买入2087.96万元，占比26.22%，卖出1843.41万元，占比23.15%。 莱茵生物今年以来股价涨2.01%，近5个交易日跌8.59%，近20日涨6.95%，近60日涨8.84%。 资料显示，桂林莱茵生物科技股份有限公司位于广西壮族自治区桂林市临桂区人民南路19号，成立日期 2000年11月28日，上市日期2007年9月13日，公司主营业务涉及主要从事天然健康产品的生产经营业 务，持续专注植物功能性成分提取领域。主营业务收入构成为：植物提取产品98.05%，其他业务产品 1.95%。 莱茵生物所属申万行业为：基础化工-化学制品-食品及饲料添加剂。所属概念板块包括：啤酒、专精特 新、融资融券、工业大麻、代糖概念等。 截至9月30日，莱茵生物股东户数4.60万，较上期减少1.66%；人均流通股16011股，较上期增加 31.16%。 ...

金融工程 证 券 研 究 报 告 市场情绪监控周报（20251229-20251231） 深度学习因子 12 月超额 5.46%，本周热度变化最 大行业为有石油石化、建筑装饰 本周情绪因子跟踪 本周宽基热度变化方面：热度变化率最大的中证 500，相比上周提高 3.45%， 最小的为"其他"，相比上周降低 2.39%；宽基热度动量组合 25 年累计收益为 36.8%。 本周申万行业热度变化方面，一级行业中热度变化率正向变化前 5 的一级行 业分别为石油石化、建筑装饰、基础化工、机械设备、家用电器，负向变化前 5 的一级行业分别为农林牧渔、社会服务、商贸零售、食品饮料、煤炭；申万 二级行业中，热度正向变化率最大的 5 个行业是电机Ⅱ、装修装饰Ⅱ、炼化及 贸易、航运港口、化学纤维。 本周概念热度变化最大的 5 个概念为华为盘古、移动支付、代糖概念、减速 器、PEEK 材料；高热度概念+低热度个股组合 25 年累计收益为 41.8%。 本周市场估值跟踪 本周宽基和行业估值： 沪深 300、中证 500、中证 1000 的滚动 5 年历史分位数分别为 90%、97%、 94%。 申万一级行业中，从 2015 年开始回溯 ...

- The report introduces a "Total Heat Indicator" for monitoring market sentiment, which aggregates the total heat indicators of individual stocks within broad-based indices, industries, and concepts[7] - The total heat indicator for individual stocks is defined as the sum of browsing, self-selection, and click counts, normalized by the market share on the same day, and then multiplied by 10,000, with a value range of [0,10000][7] - The report constructs a rotation strategy based on the weekly heat change rate (MA2) of broad-based indices, buying the index with the highest heat change rate at the end of each week, and staying out of the market if the "others" group has the highest change rate[13][16] - The rotation strategy based on the heat change rate (MA2) of broad-based indices has an annualized return of 8.74% since 2017, with a maximum drawdown of 23.5%, and a return of 36.71% in 2025[16] - The report also constructs two simple portfolios based on concept heat: a "TOP" portfolio consisting of the top 10 stocks with the highest total heat in the hottest concepts, and a "BOTTOM" portfolio consisting of the bottom 10 stocks with the lowest total heat in the hottest concepts[32][33] - The "BOTTOM" portfolio historically achieved an annualized return of 15.71% with a maximum drawdown of 28.89%, and a return of 42.4% in 2025[34] - The heat change rate (MA2) for broad-based indices this week shows that the CSI 500 index has the highest increase of 7.1%, while the CSI 300 index has the largest decrease of 5.08%[2][16] - The heat change rate (MA2) for Shenwan primary industries this week shows that the top five industries with the highest positive change rates are retail, building materials, automotive, basic chemicals, and petroleum and petrochemicals, while the top five industries with the highest negative change rates are banking, coal, media, computer, and electronics[2][27] - The heat change rate (MA2) for Shenwan secondary industries this week shows that the top five industries with the highest positive change rates are environmental equipment II, special steel II, glass fiber, beverage and dairy, and aerospace equipment II[2][27] - The top five concepts with the highest heat change rates this week are sugar substitute, automotive dismantling, civil explosives, Hainan Free Trade Zone, and PVDF concept[2][28]

12月26日，金禾实业盘中上涨2.07%，截至13:35，报21.68元/股，成交1.62亿元，换手率1.34%，总市值 123.21亿元。 资金流向方面，主力资金净流出675.48万元，特大单买入115.78万元，占比0.71%，卖出474.86万元，占 比2.93%；大单买入3621.24万元，占比22.31%，卖出3937.64万元，占比24.26%。 金禾实业今年以来股价跌1.59%，近5个交易日涨3.88%，近20日涨6.59%，近60日涨4.03%。 责任编辑：小浪快报 金禾实业所属申万行业为：基础化工-化学制品-食品及饲料添加剂。所属概念板块包括：煤化工、代糖 概念、合成生物、锂电池、中盘等。 截至9月30日，金禾实业股东户数3.90万，较上期增加14.63%；人均流通股14516股，较上期减少 12.76%。2025年1月-9月，金禾实业实现营业收入35.43亿元，同比减少12.35%；归母净利润3.91亿元， 同比减少4.44%。 分红方面，金禾实业A股上市后累计派现30.17亿元。近三年，累计派现10.05亿元。 机构持仓方面，截止2025年9月30日，金禾实业十大流通股东中，香港中央结算 ...

12月26日，凯盛新材盘中下跌2.01%，截至10:00，报28.30元/股，成交3.11亿元，换手率2.77%，总市值 119.04亿元。 资金流向方面，主力资金净流出3733.70万元，特大单买入921.31万元，占比2.96%，卖出1903.83万元， 占比6.12%；大单买入6328.54万元，占比20.34%，卖出9079.73万元，占比29.18%。 凯盛新材今年以来股价涨92.26%，近5个交易日跌0.25%，近20日涨5.83%，近60日涨26.91%。 责任编辑：小浪快报 截至12月19日，凯盛新材股东户数4.83万，较上期增加10.30%；人均流通股8091股，较上期减少 9.34%。2025年1月-9月，凯盛新材实现营业收入7.74亿元，同比增长11.22%；归母净利润1.16亿元，同 比增长121.56%。 分红方面，凯盛新材A股上市后累计派现2.94亿元。近三年，累计派现1.89亿元。 机构持仓方面，截止2025年9月30日，凯盛新材十大流通股东中，香港中央结算有限公司位居第七大流 通股东，持股260.49万股，相比上期减少64.73万股。 资料显示，山东凯盛新材料股份有限公司位于山 ...

来源：新浪证券-红岸工作室 12月25日，百龙创园涨1.92%，成交额9861.24万元，换手率1.08%，总市值91.60亿元。 异动分析 代糖概念+参股银行+人民币贬值受益+专精特新 1、公司生产的健康甜味剂产品主要为阿洛酮糖，阿洛酮糖是在自然界中天然存在但含量极少的一种稀 有单糖，其甜味及口感与蔗糖相当类似或接近，但其热量却远低于蔗糖，对于肥胖以及糖尿病患者是一 种理想的蔗糖代替物。 2、2024年半年报，公司持有山东禹城农村商业银行股份有限公司 5.14%股份。 3、根据2024年年报，公司海外营收占比为60.62%，受益于人民币贬值。 4、专精特新"小巨人"企业是全国中小企业评定工作中最高等级、最具权威的荣誉称号，是指专注于细 分市场、创新能力强、市场占有率高、掌握关键核心技术、质量效益优的排头兵企业，对于提升中小企 业自身的竞争力，以及提升产业链、供应链稳定性和竞争力具有重大意义。公司已入选工信部专精特新 小巨人企业名单。 (免责声明：分析内容来源于互联网，不构成投资建议，请投资者根据不同行情独立判断) 区间今日近3日近5日近10日近20日主力净流入-240.08万-1154.10万-2480.7 ...

资金流向方面，主力资金净流出4863.30万元，特大单买入1389.02万元，占比5.57%，卖出7028.65万 元，占比28.17%；大单买入5585.97万元，占比22.39%，卖出4809.64万元，占比19.28%。 莱茵生物今年以来股价涨27.10%，近5个交易日涨7.58%，近20日涨12.48%，近60日涨18.16%。 12月25日，莱茵生物（维权）盘中下跌2.09%，截至09:35，报9.37元/股，成交2.49亿元，换手率 3.42%，总市值69.49亿元。 资料显示，桂林莱茵生物科技股份有限公司位于广西壮族自治区桂林市临桂区人民南路19号，成立日期 2000年11月28日，上市日期2007年9月13日，公司主营业务涉及主要从事天然健康产品的生产经营业 务，持续专注植物功能性成分提取领域。主营业务收入构成为：植物提取产品98.05%，其他业务产品 1.95%。 莱茵生物所属申万行业为：基础化工-化学制品-食品及饲料添加剂。所属概念板块包括：专精特新、啤 酒、融资融券、小盘、代糖概念等。 截至9月30日，莱茵生物股东户数4.60万，较上期减少1.66%；人均流通股16011股，较上期增加 ...

12月18日，保龄宝盘中上涨2.01%，截至13:27，报9.15元/股，成交5651.47万元，换手率1.69%，总市值 34.82亿元。 资金流向方面，主力资金净流入348.18万元，特大单买入145.56万元，占比2.58%，卖出0.00元，占比 0.00%；大单买入966.92万元，占比17.11%，卖出764.30万元，占比13.52%。 保龄宝今年以来股价涨25.00%，近5个交易日涨4.69%，近20日跌3.68%，近60日跌10.99%。 保龄宝所属申万行业为：农林牧渔-农产品加工-其他农产品加工。所属概念板块包括：代糖概念、合成 生物、生物医药、小盘、增持回购等。 截至12月10日，保龄宝股东户数3.43万，较上期减少0.37%；人均流通股10773股，较上期增加0.38%。 2025年1月-9月，保龄宝实现营业收入21.26亿元，同比增长15.98%；归母净利润1.34亿元，同比增长 32.58%。 分红方面，保龄宝A股上市后累计派现3.09亿元。近三年，累计派现9507.22万元。 责任编辑：小浪快报 今年以来保龄宝已经5次登上龙虎榜，最近一次登上龙虎榜为5月22日，当日龙虎榜净买入-5 ...

Core Viewpoint - The company, Shandong Bailong Chuangyuan Biotechnology Co., Ltd., is experiencing positive market movements, with a recent stock price increase and significant revenue growth, driven by its innovative health sweetener products and strategic investments in the banking sector [1][8]. Group 1: Company Overview - The company specializes in the research, production, and sales of prebiotic series products, dietary fiber series products, and health sweetener products, with a revenue composition of 54.15% from dietary fiber, 28.00% from prebiotics, 13.57% from health sweeteners, and 3.91% from other products [8]. - As of December 10, the company had 12,300 shareholders, an increase of 12.12% from the previous period, with an average of 34,216 circulating shares per shareholder, a decrease of 10.81% [8]. - The company was established on December 30, 2005, and went public on April 21, 2021, located in the Dezhou (Yucheng) National High-tech Industrial Development Zone [8]. Group 2: Financial Performance - For the period from January to September 2025, the company achieved a revenue of 969 million yuan, representing a year-on-year growth of 18.10%, and a net profit attributable to shareholders of 265 million yuan, up 44.93% year-on-year [8]. - The company has distributed a total of 204 million yuan in dividends since its A-share listing, with 193 million yuan distributed over the past three years [9]. Group 3: Market Position and Strategic Advantages - The company produces allulose, a rare monosaccharide that serves as a low-calorie alternative to sucrose, making it ideal for individuals with obesity and diabetes [2]. - The company holds a 5.14% stake in Shandong Yucheng Rural Commercial Bank, benefiting from the depreciation of the RMB [3][4]. - The company has been recognized as a "specialized, refined, characteristic, and innovative" small giant enterprise, which enhances its competitiveness and stability within the industry [4]. Group 4: Stock Market Activity - On December 17, the company's stock rose by 2.68%, with a trading volume of 100 million yuan and a turnover rate of 1.14%, leading to a total market capitalization of 8.862 billion yuan [1]. - The average trading cost of the stock is 20.54 yuan, with the stock price approaching a resistance level of 21.24 yuan, indicating potential for upward movement if this level is surpassed [7].